Free Trial

Neumora Therapeutics (NMRA) Institutional Ownership

$9.69
+0.18 (+1.89%)
(As of 05/30/2024 ET)

Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)

Current
Institutional Ownership
Percentage
47.65%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$204.45M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$641.08K
Get NMRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NMRA Institutional Buying and Selling by Quarter

Neumora Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Artal Group S.A.2,924,052$40.21M1.0%+14.5%1.833%
5/16/2024 Kennedy Capital Management LLC136,828$1.88M0.0%N/A0.086%
5/15/2024 Baker BROS. Advisors LP633,851$8.72M0.1%N/A0.397%
5/15/2024 Price T Rowe Associates Inc. MD752,924$10.35M0.0%N/A0.472%
5/14/2024 Nan Fung Group Holdings Ltd63,315$871K0.8%N/A0.040%
5/10/2024 Vanguard Group Inc.334,330$4.60M0.0%-12.2%0.210%
5/3/2024 Callan Capital LLC204,987$2.82M0.2%N/A0.129%
5/1/2024 Auour Investments LLC105,087$1.45M0.5%N/A0.066%
4/23/2024 Addis & Hill Inc314,821$4.19M3.6%N/A0.198%
4/22/2024 Windmill Hill Asset Management Ltd26,121$359K0.1%N/A0.016%
2/14/2024 Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304%
2/13/2024 Tower Research Capital LLC TRC2,558$44K0.0%N/A0.002%
2/6/2024 Amalgamated Bank1,709$29K0.0%N/A0.001%
2/1/2024 New York State Common Retirement Fund6,900$118K0.0%N/A0.005%
1/30/2024 Strs Ohio3,200$54K0.0%N/A0.002%
1/12/2024 SG Americas Securities LLC6,308$108K0.0%N/A0.004%
12/6/2023 Citigroup Inc.14,416$203K0.0%N/A0.009%
11/15/2023 Laurion Capital Management LP21,557$304K0.0%N/A0.014%
11/14/2023 Soros Fund Management LLC10,000$141K0.0%N/A0.007%
11/14/2023 Avidity Partners Management LP1,800,000$25.40M1.0%N/A1.179%
11/13/2023 FMR LLC5,624,353$79.36M0.0%N/A3.683%
11/9/2023 Johnson & Johnson912,128$12.87M4.7%N/A0.597%
10/23/2023 WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST3,309,124$46.69M0.6%N/A2.178%
(Data available from 1/1/2016 forward)

NMRA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NMRA shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($79.36M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Artal Group S.A. ($40.21M), Avidity Partners Management LP ($33.94M), Johnson & Johnson ($12.87M), Price T Rowe Associates Inc. MD ($10.35M), and Baker BROS. Advisors LP ($8.72M).Learn more on NMRA's institutional investors.

What percentage of Neumora Therapeutics stock is owned by institutional investors?

47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings.

Which institutional investors have been buying Neumora Therapeutics stock?

Of the 21 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Avidity Partners Management LP ($1.99M), Johnson & Johnson ($912.13K), Price T Rowe Associates Inc. MD ($752.92K), Baker BROS. Advisors LP ($633.85K), and Artal Group S.A. ($371.35K).

How much institutional buying is happening at Neumora Therapeutics?

Institutional investors have bought a total of 14,512,169 shares in the last 24 months. This purchase volume represents approximately $204.45M in transactions.

Which Neumora Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Neumora Therapeutics stock in the last 24 months: Vanguard Group Inc. ($46.62K).

How much institutional selling is happening at Neumora Therapeutics?

Institutional investors have sold a total of 46,624 shares in the last 24 months. This volume of shares sold represents approximately $641.08K in transactions.


This page (NASDAQ:NMRA) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners